Bifidobacteria promote local anti-CD47 to tumor immunotherapy by accumulating in the TME, which effectively stimulates the stimulator of interferon genes signaling and increases the cross-initiation of dendritic cells (DCs) after anti-CD47 treatment. The gene discussed is CD47; the disease is neoplasm.